drugset / Trial / NCT05958069

The Efficacy and Safety of Minocycline in the Treatment of Drug-resistant Epilepsy in NORSE Patients

NCT05958069

Unknown 25 enrolled Xijing Hospital
NaSingle-groupOpen-labelTreatment

Summary

Exploring the efficacy and safety of oral minocycline combined with antiepileptic drugs in the treatment of drug-resistant epilepsy in NORSE patients, obtaining preliminary research data, and providing evidence and data support for the next large-scale randomized controlled clinical study.

Timeline

Start
2023-03-01
Primary completion
2024-03-01
Completion
2025-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Minocycline Small molecule 100 mg Oral

Indications